The Indefinite Delivery Contract (IDC) 75N93024D00028 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Tennessee, a non-profit educational institution. The $146.3M contract has an ordering period ending in July 2031 and covers the development and use of animal and animal replacement models to evaluate candidate countermeasures (e.g., therapeutics, vaccines,...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Texas Medical Branch at Galveston (UTMB) to provide preclinical models and services for the development and evaluation of medical countermeasures against infectious diseases. The $146.3M single-award IDC has a 7-year ordering period and covers four task areas: (A) small animal...
This Indefinite Delivery Contract (IDC), awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, is focused on providing pre-clinical models of infectious diseases. The $146.3 million single-award contract was granted to The Regents of the University of California, San Francisco (UCSF), a U.S. state government and educational institution, for a period of performance from July 2024 through April 2030. The contract aims to develop and refine animal and...
The indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Georgia Research Foundation, Inc. (UGA Research Foundation), a non-profit organization. The single-award IDC has a ceiling value of $146.3 million over 7 years and focuses on developing and employing animal and animal replacement models of infectious diseases to support NIAID's pandemic preparedness...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The University of North Texas Health Science Center at Fort Worth (UNTHSC) as a single award with a $146,300,000 ceiling value and a period of performance through July 2031. The contract is for the provision of pre-clinical models of infectious diseases, including the development and refinement of small animal, non-human primate, and animal...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Emory University, a private research university. The contract has a ceiling value of $146,300,000 and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with the capability to develop, refine, and employ small animal models, non-human primate models, animal...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Charles Stark Draper Laboratory, Inc. (Draper) for the development and employment of animal and animal replacement models of infectious diseases. The $146.3 million single-award IDC has a 7-year ordering period and supports the full range of preclinical evaluations, including screening, product evaluation, and eventual clinical evaluation of...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to The Trustees of the University of Pennsylvania (Penn) for the development and use of animal and animal replacement models to evaluate candidate countermeasures (vaccines, therapeutics, diagnostics) against infectious diseases. The $146.3 million single-award IDC has a 7-year ordering period and covers four task areas: (A) small animal models, (B)...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Utah State University (USU) on July 15, 2024. The $146.3 million, single-award IDC has a period of performance through July 14, 2031 and is focused on providing pre-clinical models of infectious diseases.
The contract aims to procure a range of services from USU, including the development and refinement of small animal, non-human primate, and alternative animal models to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of candidate countermeasures (vaccines, therapeutics, diagnostics) against priority infectious agents such as RNA viruses with pandemic potential, antimicrobial resistant infections, and neglected tropical diseases. The contract also includes the generation and distribution of specialized reagents needed to support this testing. No set-aside was used for this procurement. The work will primarily be performed at USU's facilities in Logan, Utah.